Reuters: Regulatory News: Bristol-Myers executive charged with insider trading

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Bristol-Myers executive charged with insider trading Aug 2nd 2012, 14:34 Thu Aug 2, 2012 10:34am EDT Aug 2 (Reuters) - A Bristol-Myers Squibb Co executive has been criminally charged with insider trading in call options of companies shortly before they were acquired, court papers show. Robert Ramnarine, an assistant director for capital markets in Bristol-Myers' office in Princeton, New Jersey, was charged with three counts of securities fraud, according to a criminal complaint made public on Thursday. Ramnarine, 45, lives in East Brunswick, New Jersey, according the complaint. He was arrested on Thursday morning, a spokesman for U.S. Attorney Paul Fishman in New Jersey said. It is unclear whether Ramnarine has hired a lawyer for his defense.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions